Coexistence of alternative MLL-SEPT9 fusion transcripts in an acute myeloid leukemia with t(11;17)(q23;q25)

Cancer Genetics and Cytogenetics

Volumn 197, Issue 1, 2010, Pages 60-64

  Santos, Joana ^a   Cerveira, Nuno ^a   Correia, Cecília ^a   Lisboa, Susana ^a   Pinheiro, Manuela ^a   Torres, Lurdes ^a   Bizarro, Susana ^a   Vieira, Joana ^a   Viterbo, Luisa ^a   Mariz, José M ^a   Teixeira, Manuel R ^a,b  

^a PORTUGUESE ONCOLOGY INSTITUTE   (Portugal)

^b UNIVERSITY OF PORTO   (Portugal)

Author keywords

[No Author keywords available]

Indexed keywords

CYTARABINE; DAUNORUBICIN; HYBRID PROTEIN; MIXED LINEAGE LEUKEMIA SEPTIN FUSION PROTEIN; UNCLASSIFIED DRUG;

ACUTE GRANULOCYTIC LEUKEMIA; ADULT; ALTERNATIVE RNA SPLICING; ARTICLE; CASE REPORT; CELL STRUCTURE; CYTOGENETICS; DRUG MEGADOSE; FLUORESCENCE IN SITU HYBRIDIZATION; GENE REARRANGEMENT; GENE TRANSLOCATION; HUMAN; LEUKOCYTOSIS; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; THROMBOCYTOPENIA;

ADULT; ALTERNATIVE SPLICING; CHILD; CHROMOSOMES, HUMAN, PAIR 11; CHROMOSOMES, HUMAN, PAIR 17; CYTOSKELETAL PROTEINS; GTP-BINDING PROTEINS; HUMANS; INFANT; LEUKEMIA, MYELOID, ACUTE; MALE; MIDDLE AGED; MYELOID-LYMPHOID LEUKEMIA PROTEIN; ONCOGENE PROTEINS, FUSION; RNA, MESSENGER; TRANSLOCATION, GENETIC;

EID: 74749098831     PISSN: 01654608     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cancergencyto.2009.10.010     Document Type: Article

References (31)

1. Rowley J.D. Chromosome translocations: dangerous liaisons revisited. Nat Rev Cancer 1 (2001) 245-250
2. Meyer C., Kowarz E., Hofmann J., Renneville A., Zuna J., Trka J., Ben Abdelali R., Macintyre E., De Braekeleer E., De Braekeleer M., Delabesse E., de Oliveira M.P., Cavé H., Clappier E., van Dongen J.J., Balgobind B.V., van den Heuvel-Eibrink M.M., Beverloo H.B., Panzer-Grümayer R., Teigler-Schlegel A., Harbott J., Kjeldsen E., Schnittger S., Koehl U., Gruhn B., Heidenreich O., Chan L.C., Yip S.F., Krzywinski M., Eckert C., Möricke A., Schrappe M., Alonso C.N., Schäfer B.W., Krauter J., Lee D.A., Zur Stadt U., Te Kronnie G., Sutton R., Izraeli S., Trakhtenbrot L., Lo Nigro L., Tsaur G., Fechina L., Szczepanski T., Strehl S., Ilencikova D., Molkentin M., Burmeister T., Dingermann T., Klingebiel T., and Marschalek R. New insights to the MLL recombinome of acute leukemias. Leukemia 23 (2009) 1490-1499
3. Cerveira N., Correia C., Bizarro S., Pinto C., Lisboa S., Mariz J.M., Marques M., and Teixeira M.R. SEPT2 is a new fusion partner of MLL in acute myeloid leukemia with t(2;11)(q37;q23). Oncogene 25 (2006) 6147-6152
4. Hall P.A., Jung K., Hillan K.J., and Russell S.E. Expression profiling the human septin gene family. J Pathol 206 (2005) 269-278
5. Peterson E.A., Kalikin L.M., Steels J.D., Estey M.P., Trimble W.S., and Petty E.M. Characterization of a SEPT9 interacting protein, SEPT14, a novel testis-specific septin. Mamm Genome 18 (2007) 796-807
6. Hall P.A., and Russell S.E. The pathobiology of the septin gene family. J Pathol 204 (2004) 489-505
7. Osaka M., Rowley J.D., and Zeleznik-Le N.J. MSF (MLL septin-like fusion), a fusion partner gene of MLL, in a therapy-related acute myeloid leukemia with a t(11;17)(q23;q25). Proc Natl Acad Sci U S A 96 (1999) 6428-6433
8. Taki T., Ohnishi H., Shinohara K., Sako M., Bessho F., Yanagisawa M., and Hayashi Y. AF17q25, a putative septin family gene, fuses the MLL gene in acute myeloid leukemia with t(11;17)(q23;q25). Cancer Res 59 (1999) 4261-4265
9. Yamamoto K., Shibata F., Yamaguchi M., and Miura O. Fusion of MLL and MSF in adult de novo acute myelomonocytic leukemia (M4) with t(11;17)(q23;q25). Int J Hematol 75 (2002) 503-507
10. Strehl S., König M., Meyer C., Schneider B., Harbott J., Jäger U., von Bergh A.R., Loncarevic I.F., Jarosova M., Schmidt H.H., Moore S.D., Marschalek R., and Haas O.A. Molecular dissection of t(11;17) in acute myeloid leukemia reveals a variety of gene fusions with heterogeneous fusion transcripts and multiple splice variants. Genes Chromosomes Cancer 45 (2006) 1041-1049
11. Kreuziger L.M.B., Porcher J.C., Ketterling R.P., and Steensma D.P. An MLL-SEPT9 fusion and t(11;17)(q23;q25) associated with de novo myelodysplastic syndrome. Leuk Res 31 (2007) 1145-1148
12. Kurosu T., Tsuji K., Ohki M., Miki T., Yamamoto M., Kakihana K., Koyama T., Taniguchi S., and Miura O. A variant-type MLL/SEPT9 fusion transcript in adult de novo acute monocytic leukemia (M5b) with t(11;17)(q23;q25). Int J Hematol 88 (2008) 192-196
13. Cerveira N., Santos J., Bizarro S., Costa V., Ribeiro F.R., Lisboa S., Correia C., Torres L., Vieira J., Snijder S., Mariz J.M., Norton L., Mellink C.H., Buijs A., and Teixeira M.R. Both SEPT2 and MLL are down-regulated in MLL-SEPT2 therapy-related myeloid neoplasia. BMC Cancer 9 (2009) 147
14. Schmittgen T.D., Lee E.J., Jiang J., Sarkar A., Yang L., Elton T.S., and Chen C. Real-time PCR quantification of precursor and mature microRNA. Methods 44 (2008) 31-38
15. Cerveira N., Micci F., Santos J., Pinheiro M., Correia C., Lisboa S., Bizarro S., Norton L., Heim S., and Teixeira M.R. Molecular characterization of the MLL-SEPT6 fusion gene in acute myeloid leukemia: identification of novel fusion transcripts and cloning of genomic breakpoint junctions. Haematologica 93 (2008) 1076-1080
16. Cerveira N., Santos S., Pinheiro M., and Snijder S. H van der Lelie, Mellink CH, Teixeira MR. A novel MLL-SEPT2 fusion variant in therapy-related myelodysplastic syndrome. Cancer Genet Cytogenet 185 (2008) 62-64
17. Megonigal M.D., Rappaport E.F., Jones D.H., Williams T.M., Lovett B.D., Kelly K.M., Lerou P.H., Moulton T., Budarf M.L., and Felix C.A. t(11;22)(q23;q11.2) in acute myeloid leukemia of infant twins fuses MLL with hCDCrel, a cell division cycle gene in the genomic region of deletion in DiGeorge and velocardiofacial syndromes. Proc Natl Acad Sci U S A 95 (1998) 6413-6418
18. Tatsumi K., Taki T., Taniwaki M., Nakamura H., Taguchi J., Chen Y.Z., Bessho F., Yanagisawa M., and Hayashi Y. The CDCREL1 gene fused to MLL in de novo acute myeloid leukemia with t(11;22)(q23;q11.2) and its frequent expression in myeloid leukemia cell lines. Genes Chromosomes Cancer 30 (2001) 230-235
19. Kojima K., Sakai I., Hasegawa A., Niiya H., Azuma T., Matsuo Y., Fujii N., Tanimoto M., and Fujita S. FLJ10849, a septin family gene, fuses MLL in a novel leukemia cell line CNLBC1 derived from chronic neutrophilic leukemia in transformation with t(4;11)(q21;q23). Leukemia 18 (2004) 998-1005
20. Cerveira N., Torres L., Rocha P., Bizarro S., Pereira D., Abreu J., Henrique R., Teixeira M.R., and Castedo S. Highly sensitive detection of the MGB1 transcript (mammaglobin) in the peripheral blood of breast cancer patients. Int J Cancer 108 (2004) 592-595
21. Russell S.E., and Hall P.A. Do septins have a role in cancer?. Br J Cancer 93 (2005) 499-503
22. McIlhatton M.A., Burrows J.F., Donaghy P.G., Chanduloy S., Johnston P.G., and Russell S.E. Genomic organization, complex splicing pattern and expression of a human septin gene on chromosome 17q25.3. Oncogene 20 (2001) 5930-5939
23. Yokoyama A., Somervaille T.C., Smith K.S., Rozenblatt-Rosen O., Meyerson M., and Cleary M.L. The menin tumor suppressor protein is an essential oncogenic cofactor for MLL-associated leukemogenesis. Cell 123 (2005) 207-218
24. Ayton P.M., Chen E.H., and Cleary M.L. Binding to nonmethylated CpG DNA is essential for target recognition, transactivation, and myeloid transformation by an MLL oncoprotein. Mol Cell Biol 24 (2004) 10470-10478
25. Amir S., Wang R., Matzkin H., Simons J.W., and Mabjeesh N.J. MSF-A interacts with hypoxia-inducible factor-1α and augments hypoxia-inducible factor transcriptional activation to affect tumorigenicity and angiogenesis. Cancer Res 66 (2006) 856-866
26. Gonzalez M.E., Makarova O., Peterson E.A., Privette L.M., and Petty E.M. Up-regulation of SEPT9_v1 stabilizes c-Jun-N-terminal kinase and contributes to its pro-proliferative activity in mammary epithelial cells. Cell Signal 21 (2009) 477-487
27. Bennett K.L., Karpenko M., Lin M.T., Claus R., Arab K., Dyckhoff G., Plinkert P., Herpel E., Smiraglia D., and Plass C. Frequently methylated tumor suppressor genes in head and neck squamous cell carcinoma. Cancer Res 68 (2008) 4494-4499
28. Burrows J.F., Chanduloy S., McIlhatton M.A., Nagar H., Yeates K., Donaghy P., Price J., Godwin A.K., Johnston P.G., and Russell S.E. Altered expression of the septin gene, SEPT9, in ovarian neoplasia. J Pathol 201 (2003) 581-588
29. Scott M., Hyland P.L., McGregor G., Hillan K.J., Russell S.E., and Hall P.A. Multimodality expression profiling shows SEPT9 to be overexpressed in a wide range of human tumours. Oncogene 24 (2005) 4688-4700
30. Scott M., McCluggage W.G., Hillan K.J., Hall P.A., and Russell S.E. Altered patterns of transcription of the septin gene, SEPT9, in ovarian tumorigenesis. Int J Cancer 118 (2006) 1325-1329
31. Gonzalez M.E., Peterson E.A., Privette L.M., Loffreda-Wren J.L., Kalikin L.M., and Petty E.M. High SEPT9_v1 expression in human breast cancer cells is associated with oncogenic phenotypes. Cancer Res 67 (2007) 8554-8564